












David Tsao
CTO at BillionToOne
David Tsao was the founder of BillionToOne which went through YC in S17. BillionToOne has developed a DNA molecular counter that increases the cell-free DNA diagnostics resolution by over 1,000 fold, which unlocks transformative improvements in prenatal screening and liquid biopsy for cancers. Unity Screen, BillionToOne's commercially available non-invasive prenatal test (NIPT), is the only NIPT that can assess fetal risk for both recessive conditions and aneuploidies from maternal blood.
Follow David
Previously at

Groupon

Adku
Northrop Grumman Aerospace Systems

Northrop Grumman Corporation
Alumnus of

Rice University

Princeton University